Swiss Stock Exchange Indexes Surge in First 2024 Session, Roche and Novartis Lead

2024-01-03 08:33:07

Zurich (awp) – The Swiss Stock Exchange started its first session of the new year on Wednesday with a resolute step, led by its heavyweights and ignoring mixed preliminary indications from across the Atlantic. The Dow Jones gained a few points on Tuesday, when the Nasdaq of technology stocks clearly let go.

European markets also started 2024 well before losing their momentum, warn analysts at Landesbank Baden-Württemberg (LBBW). “The initial optimism evaporated after a solid opening,” summarizes the German establishment.

At 9:10 a.m., the Swiss Market Index (SMI) rose by 1.11% to 11,261.37 points, the Swiss Leader Index (SLI) by 0.47% to 1784.98 points and the Swiss Performance Index (SPI ) by 0.92% to 114,704.63 points. Winners and losers were evenly matched among the top 30 valuations.

The Roche dividend certificate and the Novartis registered stock jumped by 3.0% each, boosting the flagship index of the Zurich market by more than 100 points. Up 2.3%, the food liner Nestlé alone made a contribution comparable to that of the pharmaceutical giants.

Roche announced the day before an acquisition in the field of diagnostics, when Novartis acquired rights in the field of gene therapies.

The poor shape of the banking behemoth UBS (-1.0%) went almost unnoticed in this context.

The dunce cap for the moment went to VAT Group (-3.0%), visibly contaminated by the profit taking observed across the Atlantic on technological stocks.

jh/al

1704272916
#Zurich #Stock #Exchange #good #resolutions #applied #exchanges #January

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.